Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 43

TuSimple delivers $1.35bn initial public offering

The CN, Goodyear, Kroger, Mando, Navistar, Nvidia, Sina, Traton, Union Pacific, UPS and US Xpress-backed autonomous truck producer was valued at more than $8.5bn in the IPO.

Apr 16, 2021

Alkami appears on public markets

The Fidelity-backed digital banking software provider has floated on the Nasdaq Global Select Market in a $180m offering priced above its range.

Apr 16, 2021

Coinbase moves to public markets

The crypto trading platform has executed a direct listing and is now valued above $85bn, six years after BBVA, New York Stock Exchange, NTT Docomo and USAA backed it at a $490m valuation.

Apr 15, 2021

Tango Therapeutics arranges reverse merger

The Gilead Sciences-backed oncology drug developer will join forces with Nasdaq-listed BCTG in a reverse takeover deal.

Apr 15, 2021

Grab takes reverse merger option

The on-demand ride provider, backed by more than a dozen corporates, has secured a $39.6bn initial pro-forma equity valuation in the deal.

Apr 13, 2021

MissFresh looks to deliver $1bn IPO

The Tencent and Lenovo-backed online grocery retailer could reportedly raise up to $1bn through a US initial public offering.

Apr 13, 2021

Brii brightens up with IPO plans

The infectious disease drug developer has applied to float in Hong Kong, which will enable the WuXi AppTec-backed 6 Dimensions Capital to exit.

Apr 13, 2021

Darktrace discloses IPO plans

The automated cybersecurity software provider, which counts SB Isat as an investor, had been reported to be seeking a $5bn valuation for its flotation.

Apr 13, 2021

Anjuke advances to IPO stage

The property service platform is set to list in Hong Kong, handing exits to 58.com, Agile, Chinachem, CSC Land, Country Garden, Henderson, NWD, SHKP, Tencent and Times Property.

Apr 12, 2021

Vaccitech shoots for US IPO

Alphabet, Tencent and Gilead Sciences are in line to achieve exits, after the vaccine developer filed to go public on the Nasdaq Global Market.

Apr 12, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here